Annual Current Liabilities
$5.65 M
+$375.00 K+7.10%
December 31, 2023
Summary
- As of February 20, 2025, SGMT annual total current liabilities is $5.65 million, with the most recent change of +$375.00 thousand (+7.10%) on December 31, 2023.
- During the last 3 years, SGMT annual current liabilities has risen by +$3.74 million (+196.02%).
- SGMT annual current liabilities is now at all-time high.
Performance
SGMT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.09 M
-$1.64 M-28.56%
September 30, 2024
Summary
- As of February 20, 2025, SGMT quarterly total current liabilities is $4.09 million, with the most recent change of -$1.64 million (-28.56%) on September 30, 2024.
- Over the past year, SGMT quarterly current liabilities has dropped by -$1.56 million (-27.63%).
- SGMT quarterly current liabilities is now -28.56% below its all-time high of $5.73 million, reached on June 30, 2024.
Performance
SGMT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SGMT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | -27.6% |
| 3 y3 years | +196.0% | -22.6% |
| 5 y5 years | +172.3% | -22.6% |
SGMT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.7% | -28.6% | +30.9% |
| 5 y | 5-year | at high | +196.0% | -28.6% | +30.9% |
| alltime | all time | at high | +196.0% | -28.6% | +30.9% |
Sagimet Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.09 M(-28.6%) |
| Jun 2024 | - | $5.73 M(+27.0%) |
| Mar 2024 | - | $4.51 M(-20.2%) |
| Dec 2023 | $5.65 M | $5.65 M(+12.0%) |
| Sep 2023 | - | $5.05 M(-4.5%) |
| Jun 2023 | - | $5.29 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $5.29 M(+0.2%) |
| Dec 2022 | $5.28 M(+116.4%) | $5.28 M(+68.9%) |
| Dec 2021 | $2.44 M(+27.7%) | - |
| Mar 2021 | - | $3.13 M |
| Dec 2020 | $1.91 M(-8.0%) | - |
| Dec 2019 | $2.08 M | - |
FAQ
- What is Sagimet Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Sagimet Biosciences?
- What is Sagimet Biosciences annual current liabilities year-on-year change?
- What is Sagimet Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sagimet Biosciences?
- What is Sagimet Biosciences quarterly current liabilities year-on-year change?
What is Sagimet Biosciences annual total current liabilities?
The current annual current liabilities of SGMT is $5.65 M
What is the all time high annual current liabilities for Sagimet Biosciences?
Sagimet Biosciences all-time high annual total current liabilities is $5.65 M
What is Sagimet Biosciences annual current liabilities year-on-year change?
Over the past year, SGMT annual total current liabilities has changed by +$375.00 K (+7.10%)
What is Sagimet Biosciences quarterly total current liabilities?
The current quarterly current liabilities of SGMT is $4.09 M
What is the all time high quarterly current liabilities for Sagimet Biosciences?
Sagimet Biosciences all-time high quarterly total current liabilities is $5.73 M
What is Sagimet Biosciences quarterly current liabilities year-on-year change?
Over the past year, SGMT quarterly total current liabilities has changed by -$1.56 M (-27.63%)